| PDF (649kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-233123
- DOI to cite this document:
- 10.5283/epub.23312
Alternative links to fulltext:Pubmed
Abstract
Targeting to specific sites of the body via colloidal carriers is sought in order to reduce drug side effects. The adsorption of plasma proteins on intravenously injected particles is regarded as the key factor in explaining their organ distribution: total bound protein, or, more likely, the presence of specific proteins and their conformation, are expected to influence macrophage uptake. ...

Owner only: item control page